Illumigene CMV
Medical Supply
Meridian Bioscience Inc.
Total Payments
$407,015
Transactions
29
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $174,277 | 10 | 0 |
| 2017 | $232,738 | 19 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $407,015 | 29 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Illumigene CMV Clinical Trial Protocol | Meridian Bioscience Inc. | $181,084 | 0 |
| Illumigene MV Clinical Trial Protocol | Meridian Bioscience Inc. | $124,387 | 0 |
| Cytomegalovirus Research Stage, Pre-Clinical Study Protocol- Specimen Collection | Meridian Bioscience Inc. | $50,818 | 0 |
| Illumigene CMV Research Agreement | Meridian Bioscience Inc. | $30,286 | 0 |
| Illumigene CMV Study | Meridian Bioscience Inc. | $11,250 | 0 |
| Curian Cdiff Alpha Study | Meridian Bioscience Inc. | $9,190 | 0 |
Top Doctors Receiving Payments for Illumigene CMV
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Little Rock, AR | $407,015 | 29 |
Ad
Manufacturing Companies
- Meridian Bioscience Inc. $407,015
Product Information
- Type Medical Supply
- Total Payments $407,015
- Total Doctors 0
- Transactions 29
About Illumigene CMV
Illumigene CMV is a medical supply associated with $407,015 in payments to 0 healthcare providers, recorded across 29 transactions in the CMS Open Payments database. The primary manufacturer is Meridian Bioscience Inc..
Payment data is available from 2017 to 2018. In 2018, $174,277 was paid across 10 transactions to 0 doctors.
The most common payment nature for Illumigene CMV is "Unspecified" ($407,015, 100.0% of total).
Illumigene CMV is associated with 6 research studies, including "Illumigene CMV Clinical Trial Protocol" ($181,084).